Our newsflash keeps you updated on our latest content, ensuring that you don't miss any of our resources between newsletters. View the latest newsflash here.
From The Team
Our April newsletter is all about EPiC! Following extensive engagement, we've redesigned the EPiC dashboard to make it easier to use. Read about what the cilazapril, diabetes and gout themes can offer you, and learn about the features and activities in EPiC.
This page provides the specific methodology used for each data story featured in EPiC Gout.
Our March newsletter covers the introduction of the COVID-19 treatment Paxlovid in New Zealand and highlights our latest educational content. You'll find new video, article, and bulletin resources covering CVD, Paxlovid, and the switch to Amgevita.
This page provides the specific methodology used for each data story featured in EPiC Diabetes.
This page provides the specific methodology used for each data story featured in EPiC Cilazapril.
Our February newsletter keeps you up-to-date on our latest resources. Check out our biological medicines resource hub, Amgevita article, and our bulletin on cardiovascular disease.
Our first newsletter for 2022 focuses on CPD and how our resources can help you meet your continuing professional development needs.
It's been an action-packed year, and we are very grateful to you for taking the time to join us on our journey. In our December newsletter we revisit five of our most popular resources from the year.
In our November newsletter we announce that the EPiC dashboard is now also available to pharmacist and nurse prescribers. We link you to our new article on rosuvastatin (funded on Special Authority from 1 December) and episode 2 of our Legendary Conversations podcast, and give you a snapshot of a whole lot of amazing events coming up.
Check out our new gout resource repository, our first Legendary Conversations podcast, and our diabetes medicines Q&A part 2 - all the latest content is in our October newsletter.
Our September newsletter keeps you updated on our latest content. Look out for our short videos, medicine algorithms and an insight into our new gout resources.